Stem cells therapy for ALS

Letizia Mazzini, Angelo Vescovi, Roberto Cantello, Maurizio Gelati, Alessandro Vercelli

Risultato della ricerca: Contributo su rivistaArticolo in rivistapeer review

Abstract

Introduction: Despite knowledge on the molecular basis of amyotrophic lateral sclerosis (ALS) having quickly progressed over the last few years, such discoveries have not yet translated into new therapeutics. With the advancement of stem cell technologies there is hope for stem cell therapeutics as novel treatments for ALS.Areas covered: We discuss in detail the therapeutic potential of different types of stem cells in preclinical and clinical works. Moreover, we address many open questions in clinical translation.Expert opinion: SC therapy is a potentially promising new treatment for ALS and the need to better understand how to develop cell-based experimental treatments, and how to implement them in clinical trials, becomes more pressing. Mesenchymal stem cells and neural fetal stem cells have emerged as safe and potentially effective cell types, but there is a need to carry out appropriately designed experimental studies to verify their long-term safety and possibly efficacy. Moreover, the cost-benefit analysis of the results must take into account the quality of life of the patients as a major end point. It is our opinion that a multicenter international clinical program aime d at fine-tuning and coordinating transplantation procedures and protocols is mandatory.

Lingua originaleInglese
pagine (da-a)187-199
Numero di pagine13
RivistaExpert Opinion on Biological Therapy
Volume16
Numero di pubblicazione2
DOI
Stato di pubblicazionePubblicato - 1 feb 2016

Fingerprint

Entra nei temi di ricerca di 'Stem cells therapy for ALS'. Insieme formano una fingerprint unica.

Cita questo